Devices and topical agents for rosacea management
- PMID: 25101340
Devices and topical agents for rosacea management
Abstract
Rosacea is a chronic inflammatory disease that predominantly affects facial skin in light-skinned individuals and can be divided into 4 subtypes. Patients can display signs of more than 1 subtype. Diffuse facial erythema is a common finding in rosacea patients and can lead to persistent erythema. Although there is no cure for rosacea, reduction of signs and symptoms can be achieved via various treatment modalities. This article reviews devices and topical agents currently available for the management of rosacea.
Similar articles
-
Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices.Cutis. 2014 Feb;93(2):71-6. Cutis. 2014. PMID: 24605343
-
Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?J Am Acad Dermatol. 2013 Dec;69(6 Suppl 1):S44-56. doi: 10.1016/j.jaad.2013.06.009. J Am Acad Dermatol. 2013. PMID: 24229637
-
Rosacea: a review of current topical, systemic and light-based therapies.G Ital Dermatol Venereol. 2009 Dec;144(6):673-88. G Ital Dermatol Venereol. 2009. PMID: 19907406 Review.
-
Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea.J Cosmet Dermatol. 2016 Dec;15(4):407-412. doi: 10.1111/jocd.12231. Epub 2016 Jul 4. J Cosmet Dermatol. 2016. PMID: 27378246
-
Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: comparison of clinical efficacy and effect on cutaneous substance (P) expression.J Cosmet Dermatol. 2013 Sep;12(3):187-94. doi: 10.1111/jocd.12048. J Cosmet Dermatol. 2013. PMID: 23992160 Clinical Trial.
Cited by
-
Laser and light-based therapies in the management of rosacea: an updated systematic review.Lasers Med Sci. 2021 Aug;36(6):1151-1160. doi: 10.1007/s10103-020-03200-1. Epub 2021 Jan 3. Lasers Med Sci. 2021. PMID: 33389310
-
Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features.J Clin Aesthet Dermatol. 2016 Jul;9(7):30-9. Epub 2016 Jul 1. J Clin Aesthet Dermatol. 2016. PMID: 27672409 Free PMC article. Review.
-
Effects of skin care habits on the development of rosacea: A multi-center retrospective case-control survey in Chinese population.PLoS One. 2020 Apr 27;15(4):e0231078. doi: 10.1371/journal.pone.0231078. eCollection 2020. PLoS One. 2020. PMID: 32339170 Free PMC article.
-
Consensus on the therapeutic management of rosacea - Brazilian Society of Dermatology.An Bras Dermatol. 2020 Nov-Dec;95 Suppl 1(Suppl 1):53-69. doi: 10.1016/j.abd.2020.08.001. Epub 2020 Oct 10. An Bras Dermatol. 2020. PMID: 33172727 Free PMC article.
-
Update on the management of rosacea.Clin Cosmet Investig Dermatol. 2015 Apr 7;8:159-77. doi: 10.2147/CCID.S58940. eCollection 2015. Clin Cosmet Investig Dermatol. 2015. PMID: 25897253 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical